![Søren Bregenholt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Søren Bregenholt
Director Ejecutivo en
ALLIGATOR BIOSCIENCE AB
.
Perfil
Søren Bregenholt currently works at Alligator Bioscience AB, as Chief Executive Officer from 2021, Medicon Valley Alliance FMBA, as Chairman, A Bioscience Incentive AB, as Chairman, Atlas Therapeutics AB, as Chairman, and Oblique Therapeutics AB, as Director.
Dr. Bregenholt also formerly worked at Macrophage Pharma Ltd., as Chief Executive Officer & Director, Novo Nordisk A, as Investment Manager, and Symphogen A, as Chief Operating Officer.
Dr. Bregenholt received his doctorate degree from the University of Copenhagen.
Últimas noticias acerca de Søren Bregenholt
Cargos activos de Søren Bregenholt
| Empresas | Cargo | Inicio |
|---|---|---|
| ALLIGATOR BIOSCIENCE AB | Director Ejecutivo | 01/06/2021 |
Medicon Valley Alliance FMBA
 Medicon Valley Alliance FMBA Miscellaneous Commercial ServicesCommercial Services Operates Danish-Swedish life science cluster Medicon Valley | Presidente | - |
A Bioscience Incentive AB | Presidente | - |
Atlas Therapeutics AB
 Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibodies drugs | Presidente | - |
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Søren Bregenholt.
| Empresas | Cargo | Fin |
|---|---|---|
| NOVO NORDISK A/S | Director de Inversiones | - |
Macrophage Pharma Ltd.
 Macrophage Pharma Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Director Ejecutivo | - |
Symphogen A/S
 Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Director de Operaciones | - |
Formación de Søren Bregenholt.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
14
Relaciones de 1er grado
9
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 9 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Alligator Bioscience AB
 Alligator Bioscience AB BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops antibodies for the treatment of cancers | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
Medicon Valley Alliance FMBA
Medicon Valley Alliance FMBA Miscellaneous Commercial ServicesCommercial Services Operates Danish-Swedish life science cluster Medicon Valley | Commercial Services |
Atlas Therapeutics AB
Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibodies drugs | Health Technology |
A Bioscience Incentive AB | |
Macrophage Pharma Ltd.
Macrophage Pharma Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Health Technology |
- Bolsa de valores
- Insiders
- Søren Bregenholt
Elige MarketScreener 
